Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8877776 (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

Patent 8877776 was granted and assigned to Exelixis on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Exelixis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88777760

Patent Inventor Names

Peter Lamb0

William P. Gallagher0

Adrian St. Clair Brown0

Date of Patent

November 4, 2014

Patent Application Number

131450540

Date Filed

January 15, 2010

Patent Citations Received

‌

US Patent 12128039 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

‌

US Patent 11679105 Pharmaceutical compositions of cabozantinib

‌

US Patent 11760726 Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use

‌

US Patent 11969419 Method of treating cancer

‌

US Patent 12064430 Kinase inhibitor salts and compositions thereof

‌

US Patent 12064428 Kinase inhibitor salts and compositions thereof

Patent Primary Examiner

‌

Kendra D Carter

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8877776 (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API